Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012
NCT02579681
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
221
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG:
dimethyl fumarate
Sponsor
Biogen